New diagnostic technologies and therapeutic approaches are being developed and implemented which will transform patient management in the near future. As with the previous two meetings, this conference will include academic scientists and industry leaders. In addition to topics discussed at the previous personalized medicine conferences, for 2019 we plan to add speakers in particularly timely topics such as pharmacogenomics, machine learning, and high throughput drug screening, all of which have the potential to truly transform the practice of medicine.

Attendees at the previous Personalized Medicine Conferences found the mix of topics stimulating and informative.

"I love the PM conference. It provides an excellent opportunity to confer with a small group of leaders in the field at a great location to talk about real strategies for developing and implementing personalized medicine." Daryl Pritchard (Invited Speaker)

"Once again thank you for such an incredible opportunity and for putting on a brilliant conference. Hopefully I’ll see you at another event soon." Lilian Hunt (Poster Presenter, Student)

"I can't say enough thank you and all your help really made our family's trip to Cancun so enjoyable. Of course, the science was the most enjoyable piece, which would not happen without your outstanding arrangement. I look forward to the 3rd personalized medicine fusion conference…" Rong Fan (Short Talk, Delegate)

Key Sessions

• Overviews of Personalized Medicine/Precision Medicine
• Precision Diagnostics
• Cancer Genomics
• Biomarkers
• Computational Imaging
• Bioinformatics
• Machine Learning/Artificial Intelligence
  Big Data/ Data Science
• Pharmacogenomics
• Wearable technology
• Ethics panel
• High throughput drug screening of patient tumor cells to personalize cancer care

Student Offer

We are pleased to be offering a special reduced student registration fee for this conference of just $700. Visit the Prices tab for details and inclusions. 

Confirmed Speakers

Daniel Ackerman (University of Pennsylvania)
CHEMICAL SCREENING IN PATIENT-DERIVED MODELS TO ENABLE FUNCTIONAL PRECISION MEDICINE FOR HEPATOCELLULAR CARCINOMA
Nicolai Bache (EvoSep)
ADVANCING PROTEOMIC WORKFLOWS TOWARDS PRECISION MEDICINE – WHAT IS NEEDED?
Patrick Bhola (Dana-Farber Cancer Institute)
James Broach (Penn State College of Medicine)
AN INTEGRATED FRAMEWORK FOR GENOME ANALYSIS REVEALS NUMEROUS PREVIOUSLY UNRECOGNIZABLE STRUCTURAL VARIANTS IN LEUKEMIA PATIENTS’ SAMPLES
William Bush (Case Western Reserve University)
TESTING STRUCTURE-BASED HYPOTHESES USING GENOMIC SEQUENCE DATA
Sara Cherry (University of Pennsylvania)
PRECISION ONCOLOGY IN AML: SELECTING THE RIGHT DRUGS TO TREAT
Rhonda Cooper-DeHoff (University of Florida)
IMPLEMENTING PHARMACOGENETICS CLINICALLY – REAL WORLD EXPERIENCE AND LESSONS LEARNED
Dana Crawford (Case Western Reserve University)
CHALLENGES IN PRECISION MEDICINE RESEARCH: THE CLEVELAND EXPERIENCE
Greg Gibson (Georgia Tech)
TRANSCRIPTOMICS FOR PERSONALIZED MEDICINE
Marisa Juntilla (Becton, Dickinson and Company)
BUILDING TOOLS FOR MULTI-OMICS ANALYSIS IN MEDICINE
Manolis Kellis (MIT)
FROM GENOMICS TO THERAPEUTICS: DISSECTION AND MANIPULATION OF HUMAN DISEASE CIRCUITRY AT SINGLE-CELL RESOLUTION
Christopher Kemp (Fred Hutch)
PERSONALIZED CANCER MODELS FOR TARGET DEVELOPMENT AND PRECISION ONCOLOGY
Emma Lundberg (SciLifeLab)
SINGLE CELL PROTEOME VARIABILITY IN HUMAN
Anant Madabhushi (Case Western Reserve University)
PROGNOSTIC AND PREDICTIVE PATHOMICS AND RADIOMICS: IMPLICATIONS FOR PRECISION MEDICINE
Jason Moore (University of Pennsylvania)
ACCESSIBLE ARTIFICIAL INTELLIGENCE FOR PRECISION MEDICINE
Jennifer J.D. Morrissette (University of Pennsylvania)
CLINICAL GENOMICS IN HEMATOLOGICAL MALIGNANCIES: MONITORING MUTATIONS THROUGHOUT THE COURSE OF DISEASE
Joel Parker (University of North Carolina at Chapel Hill)
BIOMARKER DEVELOPMENT IN CONTEMPORARY CLINICAL TRIALS
Kathryn Phillips (UCSF)
WHO WILL PAY & WHO WILL BENEFIT FROM PRECISION MEDICINE? NAVIGATING THE ROUGH WATERS OF REIMBURSEMENT & ECONOMIC VALUE IN TURBULENT TIMES
Marylyn Ritchie (University of Pennsylvania)
WHEN PRECISION MEDICINE GETS PERSONAL   /    MACHINE LEARNING TO IDENTIFY PHENOTYPES FROM ELECTRONIC HEALTH RECORDS
David Roth (University of Pennsylvania)
IMPLEMENTING PRECISION MEDICINE
Gary Schroth (Illumina)
IMPACT OF NEXT-GENERATION SEQUENCING ON PERSONALIZED MEDICINE
Nigam Shah (Stanford University)
SHAPING THE FUTURE OF HEALTHCARE WITH AI AND MACHINE LEARNING
Michael Snyder (Stanford University)
BIG DATA AND HEALTH
Kimia Sobhani (Cedars-Sinai Medical Center)
PRECISION CLINICAL CHEMISTRY TESTING AND DIAGNOSTICS
Haiyuan Yu (Cornell University)
NOVEL ALGORITHMS AND TECHNOLOGIES TOWARDS A WHOLE-PROTEOME 3D HUMAN INTERACTOME
Zhongming Zhao (UT Health Sciences)
IDENTIFYING ACTIONABLE AND DRUGGABLE MUTATIONS FROM CANCER BIG DATA

Target Audience

This conference will appeal to a broad spectrum of researchers working on Personalized Medicine and will include Pathologists, Geneticists, Genetic Counsellors, Clinical Pharmacists, Pharmacologists, Data Scientists and Bioinformaticians.

Educational Need

This is a young and rapidly moving field of research. This meeting aims to bring together individuals from various areas of expertise in order to keep pace with the needs of Personalized Medicine.